Genscript Biotech(GNNSF)
$3.86-0.02 (-0.39%)
GNNSF
Genscript Biotech earnings date
$3.86
At close:-0.02 (-0.39%)
Genscript Biotech (GNNSF) Q2 2024 Earnings Report
23 Followers
GNNSF Q2 2024 EPS Results
- Actual EPS
- -$0.08
- Consensus EPS
- -$0.01
- Beat/Miss
- Missed by -$0.07
- One Year Ago EPS
- -$0.04
GNNSF Q2 2024 Revenue Results
- Actual Revenue
- $559.55M
- Expected Revenue
- $547.74M
- Beat/Miss
- Beat by +$11.81M
- YoY Revenue Growth
- +43.10%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/09/2024
- Time
- Before Open
- Conference Call
- Friday, August 9, 2024
GNNSF Upcoming Earnings
Genscript Biotech's next earnings date is estimated for March 24, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
GNNSF Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
GNNSF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 24, 2027 | 2026 (Q4) | 0.01- | -0.23 | ― | ― |
| Aug 17, 2026 | 2026 (Q2) | 0.00-0.06 | -0.02 | -168.18% (-0.04) | |
| Mar 15, 2026 | 2025 (Q4) | -0.03-0.23 | 1.48 | -115.54% (-1.71) | |
| Aug 17, 2025 | 2025 (Q2) | 0.08-0.02 | -0.08 | 73.49% (+0.06) | |
| Mar 12, 2025 | 2024 (Q4) | ―1.48 | -0.06 | 2449.21% (+1.54) | |
| Aug 09, 2024 | 2024 (Q2) | -0.01-0.08 | -0.04 | -88.64% (-0.04) | |
| Mar 10, 2024 | 2023 (Q4) | -0.05-0.06 | -0.04 | -40.00% (-0.02) | |
| Aug 20, 2023 | 2023 (Q2) | ―-0.04 | -0.06 | 30.16% (+0.02) | |
| May 08, 2023 | 2023 (Q1) | ―- | -0.12 | ― | |
| Mar 30, 2023 | 2022 (Q4) | -0.06-0.04 | -0.96 | 95.31% (+0.91) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


